Product Information
Prasugrel is a prodrug that is metabolized to its active form, the prasugrel metabolite (PMS), which inhibits the ADP-induced platelet activation and aggregation. The PMS has been extensively studied in clinical trials and has shown to be effective in reducing cardiovascular events. The lc-ms/ms method has been used to measure the levels of PMS in human serum samples. Significant interactions have been observed with pharmacological agents such as clopidogrel, diazepam, erythromycin, and warfarin; however, these interactions are not clinically relevant as they do not lead to an increase in adverse effects. The matrix effect is observed due to the variability in plasma concentrations of PMS based on dosage and concentration of other drugs taken simultaneously. Prasugrel also affects the pharmacokinetic properties of other drugs taken concurrently due to its inhibition of CYP2C19 activity.
Chemical properties
Technical inquiry about: 3D-FP39260 Prasugrel metabolite
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
